Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20858843 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: filgrastim;   Drug: cytarabine;   Radiation: bismuth Bi213 monoclonal antibody M195

Indicates status has not been verified in more than two years